Investigating the Role of VISTA in Myelodysplastic Syndrome: Myeloid Function, Immune Suppression, and Disease Progression

Loading...
Thumbnail Image

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Myelodysplastic syndrome (MDS) is characterized by progressive cytopenias and a substantial risk of transformation to acute myeloid leukemia. Immune dysregulation is central to the pathogenesis of MDS, and immune suppression is often associated with disease progression. However, immunotherapies such as anti-programmed cell death protein-1 therapy have shown limited efficacy in patients, indicating an incomplete understanding of immune suppression in MDS. To better characterize the immune features of MDS, I performed extensive immune phenotyping of MDS patient bone marrow (BM). I demonstrated that V-domain Ig suppressor of T cell activation (VISTA), an inhibitory immune checkpoint, is upregulated in MDS patients by CD34+ blasts and granulocytic myeloid-derived suppressor cells (G-MDSCs) compared to healthy controls, and G-MDSC VISTA expression positively correlates with T cell suppression. In studies employing the TRAF6 transgenic and NUP98-HOXD13 transgenic MDS mouse models, genetic deficiency of VISTA delayed the progression of anemia and decreased the rate of death due to severe cytopenias. Assessment of NUP98-HOXD13 transgenic mice also revealed that VISTA deletion reduced BM populations of G-MDSCs and reversed the suppression of T cells and macrophages. These findings suggest that VISTA may augment G-MDSC-mediated immune suppression and significantly contribute to ineffective hematopoiesis in MDS. Finally, functional assays performed using bone marrow-derived macrophages revealed that VISTA may drive the suppression of inflammatory activation and promote efferocytosis in myeloid cells and macrophages. Altogether, the research described in this dissertation aims to elucidate the mechanisms of VISTA-mediated immune evasion in high-risk MDS and identify a possible target for the therapeutic management of MDS.

Description

Keywords

myelodysplastic syndrome, immune evasion, immune tolerance, VISTA

Citation

Endorsement

Review

Supplemented By

Referenced By